222 related articles for article (PubMed ID: 18209189)
1. Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis.
Suwattee P; Chow S; Berg BC; Warshaw EM
Arch Dermatol; 2008 Jan; 144(1):123-5. PubMed ID: 18209189
[No Abstract] [Full Text] [Related]
2. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
Lipworth AD; Robert C; Zhu AX
Oncology; 2009; 77(5):257-71. PubMed ID: 19923864
[TBL] [Abstract][Full Text] [Related]
3. Sunitinib-induced hand-foot syndrome: a new, distinct form.
Fife DJ; Wu JJ; Behnam SE; Linden KG
Clin Exp Dermatol; 2010 Mar; 35(2):200-1. PubMed ID: 19486049
[No Abstract] [Full Text] [Related]
4. [Palmoplantar cutaneous reaction to sorafenib].
Echeverría B; Llombart B; Botella-Estrada R; Guillén C
Actas Dermosifiliogr; 2009 Oct; 100(8):736-7. PubMed ID: 19775561
[No Abstract] [Full Text] [Related]
5. Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.
McLellan B; Kerr H
Dermatol Ther; 2011; 24(4):396-400. PubMed ID: 21910797
[TBL] [Abstract][Full Text] [Related]
6. [Hand-foot syndrome after administration of tyrosinkinase inhibitors].
Bednaríková D; Kocák I
Klin Onkol; 2010; 23(5):300-5. PubMed ID: 21061680
[TBL] [Abstract][Full Text] [Related]
7. Sunitinib-induced subungual splinter haemorrhage and acral erythema.
Nakamura M; Miyachi Y
Eur J Dermatol; 2008; 18(3):344-5. PubMed ID: 18474471
[No Abstract] [Full Text] [Related]
8. Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur.
Jucglà A; Sais G; Navarro M; Peyri J
Arch Dermatol; 1995 Mar; 131(3):364-5. PubMed ID: 7887678
[No Abstract] [Full Text] [Related]
9. Chemotherapy-induced bullous acral erythema in a subject with B-cell lymphoma.
Soker M; Akdeniz S; Devecioglu C; Haspolat K
J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):490-1. PubMed ID: 11763403
[No Abstract] [Full Text] [Related]
10. [A man with blisters on hand and feet].
Gelderblom AJ; van der Rhee JI; Ouwerkerk J
Ned Tijdschr Geneeskd; 2011; 155(45):A3994. PubMed ID: 22085574
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced acral erythema (CIAE) with bullous reaction.
Azurdia RM; Clark RE; Friedmann PS
Clin Exp Dermatol; 1999 Mar; 24(2):64-6. PubMed ID: 10233654
[TBL] [Abstract][Full Text] [Related]
12. Images in clinical medicine. Chemotherapy-induced acral erythema.
Pirisi M; Soardo G
N Engl J Med; 1994 May; 330(18):1279. PubMed ID: 8145783
[No Abstract] [Full Text] [Related]
13. Erosive nappy erythema following sunitinib intake.
Kharmoum S; Errihani H
Pan Afr Med J; 2013; 14():46. PubMed ID: 23560129
[No Abstract] [Full Text] [Related]
14. Acute and painful erythema of the hands and feet. Acral erythema induced by chemotherapy.
Revenga Arranz F; Fernández-Durán DA; Grande C; Rodríguez Peralto JL; Vanaclocha Sebastián F
Arch Dermatol; 1997 Apr; 133(4):499-500, 502-3. PubMed ID: 9126025
[No Abstract] [Full Text] [Related]
15. Bullous acral erythema and concomitant pigmentation on the face and occluded skin.
Ozkaya-Bayazit E; Diz-Küçükkaya R; Akasya E; Büyükbabani N; Oncü S; Pekçelen Y
J Eur Acad Dermatol Venereol; 2000 Mar; 14(2):139-40. PubMed ID: 10972102
[No Abstract] [Full Text] [Related]
16. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Risum S; Langer SW
Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis in oncology. Hand-foot syndrome.
Jucgla A; Sais G
J Clin Oncol; 1997 Sep; 15(9):3164. PubMed ID: 9312563
[No Abstract] [Full Text] [Related]
18. Blackberry-induced hand-foot skin reaction to sunitinib.
Boone SL; Jameson G; Von Hoff D; Lacouture ME
Invest New Drugs; 2009 Aug; 27(4):389-90. PubMed ID: 18998055
[TBL] [Abstract][Full Text] [Related]
19. Palmar-plantar erythrodysaesthesia and non-pegylated liposomal doxorubicin. A case study.
Tamayo-Orbegozo E; Iruin-Sanz A; Oñate-Muzás E; Segrelles-Bellmunt G
Farm Hosp; 2011; 35(1):46-7. PubMed ID: 20619714
[No Abstract] [Full Text] [Related]
20. Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma.
Tsai KY; Yang CH; Kuo TT; Hong HS; Chang JW
J Clin Oncol; 2006 Dec; 24(36):5786-8. PubMed ID: 17179114
[No Abstract] [Full Text] [Related]
[Next] [New Search]